Long term outcome of patients with steroid-refractory acute intestinal graft versus host disease after treatment with pentostatin

Br J Haematol. 2011 Jul;154(1):143-6. doi: 10.1111/j.1365-2141.2010.08495.x. Epub 2011 Apr 8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adenosine Deaminase Inhibitors / therapeutic use*
  • Adult
  • Female
  • Graft vs Host Disease / drug therapy*
  • Hematologic Neoplasms / therapy
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Pentostatin / therapeutic use*
  • Peripheral Blood Stem Cell Transplantation
  • Retrospective Studies
  • Treatment Outcome
  • Young Adult

Substances

  • Adenosine Deaminase Inhibitors
  • Immunosuppressive Agents
  • Pentostatin